Records containing: Urinary Bladder, Overactive
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-03-14Evaluation of a Wearable Electrical Incontinence Device in Subjects: A Non-significant Risk Clinical Evaluation of FemPulse Therapy in Women With OAB
-
CLINICAL_TRIALS study record update · 2019-01-16Age-specific Prevalence and Comparisons of Urodynamics and Bladder Diary Between Overactive Bladder-wet and -Dry Women Based on Bladder Diary
-
CLINICAL_TRIALS study record update · 2018-09-06Cohort Study: Perceptual Urge Sensation
-
CLINICAL_TRIALS study record update · 2018-06-26Comparisons of Urodynamic, Bladder Diary, Quality of Life Parameters Between OAB-wet and OAB-dry Female Patients
-
CLINICAL_TRIALS study record update · 2018-05-09Treatment of Overactive Bladder, Lower Urinary Tract Symptoms and Pelvic Pain With Medium Frequency Electrotherapy (Interferential Currents)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-01-19A Telephone Call to Decrease Patient Anxiety Before Urodynamic Testing: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2017-12-11An Open-Label, Long-Term Extension, Multi-center, Sequential Dose Titration Study to Assess Safety and Efficacy of Solifenacin Succinate Suspension in Pediatric Subjects With Overactive Bladder (OAB)
-
CLINICAL_TRIALS study record update · 2017-02-03Genetic Studies of Urologic Chronic Pelvic Pain Syndrome
-
CLINICAL_TRIALS study record update · 2017-01-30A Phase 3, Double-Blind, Randomized, Multi-center, Placebo-Controlled Sequential Dose Titration Study to Assess Efficacy, Safety and Population Pharmacokinetics of Solifenacin Succinate Suspension in Pediatric Subjects From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB)
-
CLINICAL_TRIALS study record update · 2017-01-04EMED Detruset Intravesical Electrical Stimulation Catheter for Treatment of Urge Urinary Incontinence and Overactive Bladder Syndrome in Females
-
CLINICAL_TRIALS study record update · 2016-10-24ClinicalTrials.gov study NCT02673047
-
CLINICAL_TRIALS study record update · 2016-09-22ClinicalTrials.gov study NCT02010788
-
CLINICAL_TRIALS study record update · 2016-09-13Czech Observational Study to Evaluate Quality of Life in Patients Switched to Vesicare™ (Solifenacin) From Other Antimuscarinics
-
CLINICAL_TRIALS study record update · 2016-09-02ClinicalTrials.gov study NCT02557971
-
CLINICAL_TRIALS study record update · 2016-08-30A Double-Blind, Randomized, Parallel Group, Multi-Centre Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Subjects With Overactive Bladder (OAB) Treated With Antimuscarinics and Dissatisfied Due to Lack of Efficacy
-
CLINICAL_TRIALS study record update · 2016-08-19Open-Label, Single-Dose, Randomized, Crossover Study To Estimate The Effects Of Food On The Pharmacokinetics Of Two Fesoterodine Sustained-Release Beads-In-Capsule Formulations And To Estimate The Relative Bioavailability Of One Or Both Formulations Compared To Commercial Tablet Formulation In Healthy Adult Volunteers
-
CLINICAL_TRIALS study record update · 2016-07-12The Effect of Anticholinergics on Cognitive Function in the Elderly: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2016-06-17A Phase IIb Randomized, Placebo- and Active Comparator (Tolterodine)-Controlled, 2-Part Clinical Study of the Efficacy and Safety of MK-4618 in Patients With Overactive Bladder A 52-week Extension to: A Phase IIb Randomized, Placebo- and Active Comparator (Tolterodine)-Controlled, 2-Part Clinical Study of the Efficacy and Safety of MK-4618 in Patients With Overactive Bladder
-
CLINICAL_TRIALS study record update · 2016-04-18ClinicalTrials.gov study NCT02161159
-
CLINICAL_TRIALS study record update · 2016-03-07Comparative Effectiveness of Three Different Teaching Methods in Behavioural Therapy Program for Female Overactive Bladder: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2016-02-02Comparison of the Effect of Flexible Dosage of Solifenacin Succinate Between Patients Who Have Frequent Micturition With and Without Urgency
-
CLINICAL_TRIALS study record update · 2016-01-07A Randomized, Double Blind, Placebo-Controlled, Parallel Group Comparison of the Efficacy and Safety of Any Alpha Blocker Monotherapy and Any Alpha Blocker Plus Solifenacin in Men With Residual Overactive Bladder Symptoms of Urinary Frequency and Urgency With/Without Urgency Incontinence After Previous Monotherapy With Any Alpha Blocker
-
CLINICAL_TRIALS study record update · 2016-01-05Long-term Study of YM178: Long Term Study of YM178 in Subjects With Overactive Bladder
-
CLINICAL_TRIALS study record update · 2015-12-31Overactive Bladder Education
-
CLINICAL_TRIALS study record update · 2015-07-21A Randomized, Double-Blind, Factorial, Parallel-Group, Active and Placebo-Controlled, Multicenter Dose-Ranging Study to Evaluate the Efficacy, Safety and Tolerability of Six Dose Combinations of Solifenacin Succinate and Mirabegron Compared to Mirabegron and Solifenacin Succinate Monotherapies in the Treatment of Overactive Bladder.